Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Bladder Cancer

Free Subscription 13.11.2023 1 Am J Clin Exp Urol 1 Anal Chim Acta 1 Appl Bionics Biomech 3 Asian J Surg 3 Bladder (San Franc) 1 BMC Cancer 1 BMC Med Imaging 1 Can Urol Assoc J 1 Cancer Diagn Progn 1 Comput Math Methods Med 1 Diagn Pathol 1 Epigenomics 1 Eur Radiol 1 Eur Urol Focus 1 Exploration (Beijing) 1 FASEB J 1 Gene 1 Histochem Cell Biol 1 Histol Histopathol 1 IJU Case Rep 1 Int J Hyperthermia 4 Investig Clin Urol 1 Iran J Pathol 1 J Biomed Res 1 J Cancer Res Clin Oncol 1 J Med Invest 1 J Urol 1 JAMA 1 N Engl J Med 1 Nature 2 Sci Rep 1 Tissue Cell 1 Toxicol Appl Pharmacol 1 Urol Clin North Am 8 Urol Oncol 1 Urologie 1 Urology 3 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Exp Urol

1. MOHAMED NE, Leung TM, Benn EK, Korn TG, et al
   Depression and anxiety among patients treated for bladder cancer: examining clinical, demographic, and psychosocial predictors.
   Am J Clin Exp Urol. 2023;11:401-413.
   PubMed         Abstract available
   
   

   
   Anal Chim Acta

2. YANG M, Wang J, Quan S, Xu Q, et al
   High-precision bladder cancer diagnosis method: 2D Raman spectrum figures based on maintenance technology combined with automatic weighted feature fusion network.
   Anal Chim Acta. 2023;1282:341908.
   PubMed         Abstract available
   
   

   
   Appl Bionics Biomech

3. AND BIOMECHANICS AB
   Retracted: Applications of Bladder Cancer Data Using a Modified Log-Logistic Model.
   Appl Bionics Biomech. 2023;2023:9789308.
   PubMed         Abstract available
   
   

   
   Asian J Surg

4. YANG B, Wang D, Niu Y, Liu J, et al
   A carcinoma in situ was inadvertently discovered after surgery for urinary bladder contracture.
   Asian J Surg. 2023;46:4897-4898.
   PubMed        
   
   
5. XIA M, Xiong S, He F, Li X, et al
   Pelvic lipomatosis with mucinous adenocarcinoma: A case report and literature review.
   Asian J Surg. 2023;46:4889-4890.
   PubMed        
   
   
6. HE B, Ye L, Zeng H, Yao J, et al
   Differentiation of urothelial carcinoma and neuroendocrine carcinoma in the urinary bladder based on CT texture analysis.
   Asian J Surg. 2023;46:5053-5054.
   PubMed        
   
   

   
   Bladder (San Franc)

7. FU W, Zhang X
   Laparoscopic and Robotic-Assisted Extended Pelvic Lymph Node Dissection for Invasive Bladder Cancer: A Review.
   Bladder (San Franc). 2023;10:e21200004.
   PubMed         Abstract available
   
   
8. CHEN B, Shu B, Liu Z, Zhu J, et al
   The diagnostic value of fluorescence in situ hybridization in secondary electroresection of bladder cancer.
   Bladder (San Franc). 2023;10:e21200006.
   PubMed         Abstract available
   
   
9. GU Y, Lu Y, Xiong Y, Zhan X, et al
   Advances in the bladder cancer research using 3D culture models.
   Bladder (San Franc). 2023;10:e21200005.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LU L, Chen C, Cheng H, Ding H, et al
    Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1066.
    PubMed         Abstract available
    
    

    
    BMC Med Imaging

11. JIA ZY, Yang F, Zhang W, Li WW, et al
    Application of contrast-enhanced ultrasound in renal space-occupying lesion puncture biopsy.
    BMC Med Imaging. 2023;23:178.
    PubMed         Abstract available
    
    

    
    Can Urol Assoc J

12. RIVEROS C, Ranganathan S, Haque W, Huang E, et al
    Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation.
    Can Urol Assoc J. 2023 Oct 23. doi: 10.5489/cuaj.8386.
    PubMed         Abstract available
    
    

    
    Cancer Diagn Progn

13. KARAN C, Yaren A, Demirel BC, Dogan T, et al
    Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
    Cancer Diagn Progn. 2023;3:706-715.
    PubMed         Abstract available
    
    

    
    Comput Math Methods Med

14. METHODS IN MEDICINE CAM
    Retracted: Computed Tomography Image Features under Deep Learning Algorithm Applied in Staging Diagnosis of Bladder Cancer and Detection on Ceramide Glycosylation.
    Comput Math Methods Med. 2023;2023:9842436.
    PubMed         Abstract available
    
    

    
    Diagn Pathol

15. LI D, Liu F, Chen Y, Li P, et al
    Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
    Diagn Pathol. 2023;18:120.
    PubMed         Abstract available
    
    

    
    Epigenomics

16. WANG X, Wang Z, Wei Q, Wang H, et al
    Anoikis-associated signatures predict prognosis and immune response in bladder cancer.
    Epigenomics. 2023 Nov 9. doi: 10.2217/epi-2023-0240.
    PubMed         Abstract available
    
    

    
    Eur Radiol

17. XU X, Huang Y, Liu Y, Cai Q, et al
    Multiparametric MRI-based VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer?
    Eur Radiol. 2023 Nov 6. doi: 10.1007/s00330-023-10387.
    PubMed         Abstract available
    
    

    
    Eur Urol Focus

18. SORIA F, Rosazza M, Livoti S, Dutto D, et al
    Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study.
    Eur Urol Focus. 2023 Nov 1:S2405-4569(23)00236-5. doi: 10.1016/j.euf.2023.
    PubMed         Abstract available
    
    

    
    Exploration (Beijing)

19. LI G, Song Z, Ru Y, Zhang J, et al
    Small-molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual-inhibiting properties for bladder cancer treatment.
    Exploration (Beijing). 2023;3:20220141.
    PubMed         Abstract available
    
    

    
    FASEB J

20. CHEN H, Ma L, Yang W, Li Y, et al
    POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer.
    FASEB J. 2023;37:e23260.
    PubMed         Abstract available
    
    

    
    Gene

21. CAO Y, Zou Z, Wu X, Li W, et al
    LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3.
    Gene. 2023 Nov 7:147974. doi: 10.1016/j.gene.2023.147974.
    PubMed         Abstract available
    
    

    
    Histochem Cell Biol

22. RESNIK N, Visnjar T, Smrkolj T, Kreft ME, et al
    Selective targeting of lectins and their macropinocytosis in urothelial tumours: translation from in vitro to ex vivo.
    Histochem Cell Biol. 2023;160:435-452.
    PubMed         Abstract available
    
    

    
    Histol Histopathol

23. WANG J, Luo J, Wu X, Li Z, et al
    WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
    Histol Histopathol. 2023 Oct 23:18671. doi: 10.14670.
    PubMed         Abstract available
    
    

    
    IJU Case Rep

24. ARAI Y, Goto Y, Sazuka T, Fujimoto A, et al
    A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation.
    IJU Case Rep. 2023;6:471-474.
    PubMed         Abstract available
    
    

    
    Int J Hyperthermia

25. ADEMAJ A, Puric E, Marder D, Timm O, et al
    Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results.
    Int J Hyperthermia. 2023;40:2275540.
    PubMed         Abstract available
    
    

    
    Investig Clin Urol

26. EL AZAB A, Abdelbary A, El Faqeh M Okasha A, Aboulkassem H, et al
    The effect of immediate neoadjuvant electromotive instillation of mitomycin C with Bacillus Calmette-Guerin versus BCG alone in non-muscle-invasive bladder cancer: A randomized controlled trial.
    Investig Clin Urol. 2023;64:554-560.
    PubMed         Abstract available
    
    
27. JAI-UA C, Limpaiboon C, Siriboonrid S, Binsri N, et al
    Accuracy of Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer detection from multiparametric magnetic resonance imaging.
    Investig Clin Urol. 2023;64:546-553.
    PubMed         Abstract available
    
    
28. DURSUN F, Elshabrawy A, Wang H, Kaushik D, et al
    Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma.
    Investig Clin Urol. 2023;64:561-571.
    PubMed         Abstract available
    
    
29. JEON J, Ha JS, Shin SJ, Ham WS, et al
    Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy.
    Investig Clin Urol. 2023;64:597-605.
    PubMed         Abstract available
    
    

    
    Iran J Pathol

30. FARNAZ T, Bhattacharjee P, Ahamad MSU, Rima SA, et al
    The Prevalence of p16 Expression in Urothelial Bladder Cancer in a Tertiary Care Hospital of Chattogram, Bangladesh.
    Iran J Pathol. 2023;18:306-311.
    PubMed         Abstract available
    
    

    
    J Biomed Res

31. LIU T, Gu J, Li C, Guo M, et al
    Alternative polyadenylation-related genetic variants contribute to bladder cancer risk.
    J Biomed Res. 2023 Nov 15:1-13. doi: 10.7555/JBR.37.20230063.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

32. WEI X, Jiang Y, Yang G, Chang T, et al
    MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity.
    J Cancer Res Clin Oncol. 2023 Nov 8. doi: 10.1007/s00432-023-05484.
    PubMed         Abstract available
    
    

    
    J Med Invest

33. TANIUCHI M, Yanagi M, Kiriyama T, Akatsuka J, et al
    Primary leiomyoma of the bladder radiologically mimicking a retroperitoneal tumor - a case report.
    J Med Invest. 2023;70.
    PubMed         Abstract available
    
    

    
    J Urol

34. SOOD A, Rudzinski JK, Labbate CV, Hensley PJ, et al
    Long-Term Oncological Outcomes in Patients Diagnosed with Non-Metastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.
    J Urol. 2023 Nov 3:101097JU0000000000003778. doi: 10.1097/JU.0000000000003778.
    PubMed         Abstract available
    
    

    
    JAMA

35. KSHATTRY S, Parker TL, Huntington SF
    Peripheral Blasts in a Patient Receiving Chemotherapy.
    JAMA. 2023;330:1581-1582.
    PubMed        
    
    

    
    N Engl J Med

36. VAN DER HEIJDEN MS, Sonpavde G, Powles T, Necchi A, et al
    Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
    N Engl J Med. 2023;389:1778-1789.
    PubMed         Abstract available
    
    

    
    Nature

37. LEDFORD H
    Cancer trial results show power of weaponized antibodies.
    Nature. 2023;623:231-232.
    PubMed        
    
    

    
    Sci Rep

38. JANEV A, Ramuta TZ, Jerman UD, Obradovic H, et al
    Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.
    Sci Rep. 2023;13:19227.
    PubMed         Abstract available
    
    
39. OGURA R, Ito S, Ueda T, Gabata Y, et al
    Screening for a practical method to monitor the status of patients with metastatic bladder cancer at the circulating cell-gene level.
    Sci Rep. 2023;13:19517.
    PubMed         Abstract available
    
    

    
    Tissue Cell

40. ZHANG L, Shao G, Shao J, Zhao J, et al
    Corrigendum to "PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-kappaB pathway" [Tissue Cell 76 (2022) 101788].
    Tissue Cell. 2023 Nov 1:102221. doi: 10.1016/j.tice.2023.102221.
    PubMed        
    
    

    
    Toxicol Appl Pharmacol

41. CUI A, Li X, Ma X, Song Z, et al
    Quantitative transcriptomic and proteomic analysis reveals corosolic acid inhibiting bladder cancer via suppressing cell cycle and inducing mitophagy in vitro and in vivo.
    Toxicol Appl Pharmacol. 2023 Nov 6:116749. doi: 10.1016/j.taap.2023.116749.
    PubMed         Abstract available
    
    

    
    Urol Clin North Am

42. LAURIE MA, Zhou SR, Islam MT, Shkolyar E, et al
    Bladder Cancer and Artificial Intelligence: Emerging Applications.
    Urol Clin North Am. 2024;51:63-75.
    PubMed         Abstract available
    
    

    
    Urol Oncol

43. ATIQ S, Hirshman N, Shariff A, Zhang T, et al
    The management of toxicities from immune, targeted and ADCs treatments in patients with urothelial cancer.
    Urol Oncol. 2023;41:410-419.
    PubMed         Abstract available
    
    
44. SONG S, Smith A, Hu B
    The patient experience with localized upper tract urothelial cancer.
    Urol Oncol. 2023;41:431.
    PubMed         Abstract available
    
    
45. THOMAS J, Sun M, Getz T, Ho B, et al
    Antibody-drug conjugates for urothelial carcinoma.
    Urol Oncol. 2023;41:420-428.
    PubMed         Abstract available
    
    
46. SINGH V, Singh MK, Jain M, Pandey AK, et al
    The relationship between BCG immunotherapy and oxidative stress parameters in patients with nonmuscle invasive bladder cancer.
    Urol Oncol. 2023 Nov 4:S1078-1439(23)00321-6. doi: 10.1016/j.urolonc.2023.
    PubMed         Abstract available
    
    
47. MORENO MF, Kaul S, Fleishman A, Korets R, et al
    Conditional survival following radical cystectomy for urothelial carcinoma of the bladder.
    Urol Oncol. 2023;41:432.
    PubMed         Abstract available
    
    
48. KATIMS AB, Gaffney C, Firouzi S, Yip W, et al
    Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma.
    Urol Oncol. 2023;41:433.
    PubMed         Abstract available
    
    
49. YING Y, Zhang Z, Xing N, Qian Z, et al
    Preoperative urine sediment chromosomal instability level predicts urothelial cancer prognosis.
    Urol Oncol. 2023;41:433.
    PubMed         Abstract available
    
    
50. FALTAS B
    A new era in the treatment of urothelial carcinoma.
    Urol Oncol. 2023;41:395-397.
    PubMed         Abstract available
    
    

    
    Urologie

51. KLUMPER N, Eckstein M, Kunath F, Heidegger I, et al
    [Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma].
    Urologie. 2023;62:1193-1199.
    PubMed         Abstract available
    
    

    
    Urology

52. GALOSI AB, Fave RFD, Perpepaj L, Milanese G, et al
    Does Alexis(c) wound protector/retractor reduce the risk of surgical site infections after open radical cystectomy for bladder cancer? Results from a single center, comparative study.
    Urology. 2023 Nov 6:S0090-4295(23)00951-2. doi: 10.1016/j.urology.2023.
    PubMed         Abstract available
    
    

    
    World J Urol

53. PINAR U, Calleris G, Grobet-Jeandin E, Grande P, et al
    The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
    World J Urol. 2023;41:3205-3230.
    PubMed         Abstract available
    
    
54. GABRIEL PE, Pinar U, Lenfant L, Parra J, et al
    Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma.
    World J Urol. 2023;41:3001-3007.
    PubMed         Abstract available
    
    
55. ORTNER G, Somani BK, Guven S, Kitzbichler G, et al
    Experts' recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group.
    World J Urol. 2023;41:3367-3376.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.